Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  BioArctic AB    BIOA B   SE0010323311

BIOARCTIC AB

(BIOA B)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

BioArctic AB : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 09:15am EDT

The company will report its earnings for FY 2018 on 02/14/2019. Generally, the company reports earnings worse than estimates. In recent months, the 2 analysts from Thomson Reuters consensus have revised their EPS estimates upward.

Annual earnings per share is expected at 0.06 SEK for 2018 (- 72.7% from 2017). A summary of annual publications and estimates is available below.

Annual results20172018 (e)2019 (e)
Sales
Million SEK
Released
Forecast
Spread
141
120
18%

262

675
Operating income (EBITDA)
Million SEK
Released
Forecast
Spread
19,3
-12,0
261%

14,5

337
Operating profit (EBIT)
Million SEK
Released
Forecast
Spread
19,3
-13,5
243%

14,5

335
Pre-Tax Profit (EBT)
Million SEK
Released
Forecast
Spread
19,7
-35,0
156%

-58,0

329
Net income
Million SEK
Released
Forecast
Spread
15,2
-35,0
143%

-58,0

257
EPS
 SEK
Released
Forecast
Spread
0,22
-0,17
233%

0,06

2,96
Announcement Date02/20/2018
Stocks mentioned in the article
ChangeLast1st jan.
BIOARCTIC AB 1.98% 72 Delayed Quote.-13.23%
THOMSON REUTERS CORP 0.59% 89.83 Delayed Quote.34.04%

© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOARCTIC AB
07/18BIOARCTIC : and Eisai present new data regarding BAN2401 at the Alzheimer's Asso..
AQ
07/15BIOARCTIC : founder received AAIC Lifetime Achievement Award
AQ
07/12New Data in 2 Oral and 13 Poster Presentations about Eisai's Latest Dementia ..
AQ
07/11BIOARCTIC : Interim Report January - June 2019
AQ
07/11BIOARCTIC : and Eisai to present BAN2401 at the Alzheimer's Association Internat..
AQ
07/02BIOARCTIC : Invitation to presentation of BioArctic's Interim Report for the sec..
AQ
05/23BIOARCTIC : strengthens its blood-brain barrier technology platform with world l..
AQ
05/20BIOARCTIC : receives MEUR 15 milestone payment from Eisai for start of BAN2401 c..
AQ
05/10BIOARCTIC : Alzheimer's Clinical Trials Consortium and Eisai announce BAN2401 to..
AQ
05/09BIOARCTIC : Board of Directors and management increase their shareholdings
AQ
More news
Financials (SEK)
Sales 2019 343 M
EBIT 2019 116 M
Net income 2019 71,5 M
Finance 2019 1 158 M
Yield 2019 -
P/E ratio 2019 88,3x
P/E ratio 2020 -31,5x
EV / Sales2019 15,1x
EV / Sales2020 119x
Capitalization 6 340 M
Chart BIOARCTIC AB
Duration : Period :
BioArctic AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOARCTIC AB
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 149,33  SEK
Last Close Price 72,00  SEK
Spread / Highest target 186%
Spread / Average Target 107%
Spread / Lowest Target 59,7%
EPS Revisions
Managers
NameTitle
Gunilla Christina Osswald President & Chief Executive Officer
Wenche Nelly A. Rolfsen Sandsborg Chairman
Jan P. Mattsson Chief Financial Officer & Vice President-Finance
Christer Möller CSO & VP-Pre-Clinical Development
Hans Basun Chief Medical Officer & VP-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
BIOARCTIC AB-13.23%661
IQVIA HOLDINGS INC34.52%30 823
LONZA GROUP33.10%25 850
CELLTRION, INC.--.--%20 040
INCYTE CORPORATION28.50%17 522
EXACT SCIENCES CORPORATION82.06%14 987